StonvexLoading…
StonvexStonvexStonvexCore line items from RSKIA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-04-30 | Annual 2024 2024-04-30 | Annual 2023 2023-04-30 | Annual 2022 2022-04-30 |
|---|---|---|---|---|
Revenue | $22.54M | $21.77M | $19.98M | $20.73M |
Operating Income | $6.24M | $6.29M | $5.06M | $5.65M |
Net Income | $7.13M | $7.56M | $4.76M | $3.57M |
EPS (Diluted) | $1.45 | $1.53 | $0.96 | $0.72 |
Total Assets | $63.34M | $60.78M | $55.95M | $54.03M |
Total Liabilities | $6.48M | $6.14M | $5.30M | $4.99M |
Cash & Equivalents | $6.47M | $7.11M | $4.94M | $6.08M |
Free Cash Flow OCF − CapEx | $3.91M | $5.63M | $2.29M | $1.58M |
Shares Outstanding | 8.50M | 8.50M | 8.50M | 8.50M |